Volume 6, Issue 2 (2020)
From the Editors
Medical Social Science and Clinical Decision Science
James Peter Meza
Original Research
Clinical Decision Science: Proof of concept
James Peter Meza MD, PhD; Nicholus Yee MD; Bennett Riddering MD; Ali Nasrallah MD; and Urtė Zableckas MS, MBBS
Informed Consent
Do atypical antipsychotics trigger manic switching in patients with bipolar I disorder?
Hilary P. Stevenson MD, PhD
Clinical Decision Reports
One-stage and two-stage breast reconstruction have no meaningful difference in patient quality of life
Amer Mansoor
Inpatient motivational interviewing for adolescent type 1 diabetics with poor glycemic control is ineffective
Andrew L. Roberts
Mindfulness therapy is an effective adjunctive treatment for adolescents living with HIV
Samantha Rea
Janus kinase inhibitors may be an effective treatment to reduce skin depigmentation in vitiligo
Shannon E. Lohman
Behavioral therapy is a viable treatment option for children and adolescents with trichotillomania
Elizabeth Nesbitt
Changing guidelines: Recommendation of early peanut introduction for prevention of peanut allergy in infants with severe eczema
Alexandra H. Zetye
Little is known about cannabidiol for improving severe behavioral symptoms of autistic spectrum disorder
Keerteshwrya Mishra
Cyclosporine shows benefit as compared to methotrexate for treatment of pediatric atopic dermatitis refractory to topical medications when rapidity of clinical response is of key importance to the patient
Connor R. Buechler and Steven Daveluy MD
Medication assisted treatment with buprenorphine/naloxone or methadone: Comparitive outcomes in patients with an opioid addiction
Deepti Shanbhag
Low-dose Psoralen–UV-A maintenance therapy prolongs disease-free remission rates in mycosis fungoides patients
Joshua M. Brady
Reflections
Gut reactions and clinical decisions
Joseph Friedli MD